Literature DB >> 17503104

Prevalence of depression-PTSD comorbidity: implications for clinical practice guidelines and primary care-based interventions.

Duncan G Campbell1, Bradford L Felker, Chuan-Fen Liu, Elizabeth M Yano, JoAnn E Kirchner, Domin Chan, Lisa V Rubenstein, Edmund F Chaney.   

Abstract

BACKGROUND: Compared to those with depression alone, depressed patients with posttraumatic stress disorder (PTSD) experience more severe psychiatric symptomatology and factors that complicate treatment.
OBJECTIVE: To estimate PTSD prevalence among depressed military veteran primary care patients and compare demographic/illness characteristics of PTSD screen-positive depressed patients (MDD-PTSD+) to those with depression alone (MDD).
DESIGN: Cross-sectional comparison of MDD patients versus MDD-PTSD+ patients. PARTICIPANTS: Six hundred seventy-seven randomly sampled depressed patients with at least 1 primary care visit in the previous 12 months. Participants composed the baseline sample of a group randomized trial of collaborative care for depression in 10 VA primary care practices in 5 states. MEASUREMENTS: The Patient Health Questionnaire-9 assessed MDD. Probable PTSD was defined as a Primary Care PTSD Screen > or = 3. Regression-based techniques compared MDD and MDD-PTSD+ patients on demographic/illness characteristics.
RESULTS: Thirty-six percent of depressed patients screened positive for PTSD. Adjusting for sociodemographic differences and physical illness comorbidity, MDD-PTSD+ patients reported more severe depression (P < .001), lower social support (P < .001), more frequent outpatient health care visits (P < .001), and were more likely to report suicidal ideation (P < .001) than MDD patients. No differences were observed in alcohol consumption, self-reported general health, and physical illness comorbidity.
CONCLUSIONS: PTSD is more common among depressed primary care patients than previously thought. Comorbid PTSD among depressed patients is associated with increased illness burden, poorer prognosis, and delayed response to depression treatment. Providers should consider recommending psychotherapeutic interventions for depressed patients with PTSD.

Entities:  

Mesh:

Year:  2007        PMID: 17503104      PMCID: PMC2219856          DOI: 10.1007/s11606-006-0101-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  51 in total

1.  Subthreshold PTSD in primary care: prevalence, psychiatric disorders, healthcare use, and functional status.

Authors:  Anouk L Grubaugh; Kathryn M Magruder; Angela E Waldrop; Jon D Elhai; Rebecca G Knapp; B Christopher Frueh
Journal:  J Nerv Ment Dis       Date:  2005-10       Impact factor: 2.254

2.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

3.  Resolution of trauma-related guilt following treatment of PTSD in female rape victims: a result of cognitive processing therapy targeting comorbid depression?

Authors:  Pallavi Nishith; Reginald D V Nixon; Patricia A Resick
Journal:  J Affect Disord       Date:  2005-06       Impact factor: 4.839

4.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

5.  Posttraumatic stress disorder and comorbid major depression: is the correlation an illusion?

Authors:  E B Blanchard; T C Buckley; E J Hickling; A E Taylor
Journal:  J Anxiety Disord       Date:  1998 Jan-Feb

6.  Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression?

Authors:  B N Gaynes; K M Magruder; B J Burns; H R Wagner; K S Yarnall; W E Broadhead
Journal:  Gen Hosp Psychiatry       Date:  1999 May-Jun       Impact factor: 3.238

7.  National trends in the outpatient treatment of depression.

Authors:  Mark Olfson; Steven C Marcus; Benjamin Druss; Lynn Elinson; Terri Tanielian; Harold Alan Pincus
Journal:  JAMA       Date:  2002-01-09       Impact factor: 56.272

8.  Risk factors for late-life suicide: a prospective, community-based study.

Authors:  Carolyn L Turvey; Yeates Conwell; Michael P Jones; Caroline Phillips; Eleanor Simonsick; Jane L Pearson; Robert Wallace
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jul-Aug       Impact factor: 4.105

9.  Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial.

Authors:  Martha L Bruce; Thomas R Ten Have; Charles F Reynolds; Ira I Katz; Herbert C Schulberg; Benoit H Mulsant; Gregory K Brown; Gail J McAvay; Jane L Pearson; George S Alexopoulos
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

10.  Patterns of antidepressant use in community practice.

Authors:  G E Simon; M VonKorff; E H Wagner; W Barlow
Journal:  Gen Hosp Psychiatry       Date:  1993-11       Impact factor: 3.238

View more
  124 in total

1.  Trajectories of cannabis use beginning in adolescence associated with symptoms of posttraumatic stress disorder in the mid-thirties.

Authors:  Jung Yeon Lee; Judith S Brook; Stephen J Finch; David W Brook
Journal:  Subst Abus       Date:  2017-09-15       Impact factor: 3.716

Review 2.  The current state of intervention research for posttraumatic stress disorder within the primary care setting.

Authors:  Kyle Possemato
Journal:  J Clin Psychol Med Settings       Date:  2011-09

3.  Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.

Authors:  Matthew G Kirkpatrick; Nicholas I Goldenson; Nahel Kapadia; Christopher W Kahler; Harriet de Wit; Robert M Swift; John E McGeary; Steve Sussman; Adam M Leventhal
Journal:  Psychopharmacology (Berl)       Date:  2015-10-02       Impact factor: 4.530

4.  Cognitive behavioral therapy for posttraumatic stress disorder in individuals with severe mental illness and borderline personality disorder.

Authors:  M Alexandra Kredlow; Kristin L Szuhany; Stephen Lo; Haiyi Xie; Jennifer D Gottlieb; Stanley D Rosenberg; Kim T Mueser
Journal:  Psychiatry Res       Date:  2017-01-04       Impact factor: 3.222

5.  Gender differences in health service utilization among Iraq and Afghanistan veterans with posttraumatic stress disorder.

Authors:  Shira Maguen; Beth Cohen; Greg Cohen; Erin Madden; Daniel Bertenthal; Karen Seal
Journal:  J Womens Health (Larchmt)       Date:  2012-02-07       Impact factor: 2.681

6.  Long-term effectiveness of collaborative depression care in older primary care patients with and without PTSD symptoms.

Authors:  Domin Chan; Ming-Yu Fan; Jürgen Unützer
Journal:  Int J Geriatr Psychiatry       Date:  2010-12-09       Impact factor: 3.485

Review 7.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

8.  Intimate partner violence, depression, PTSD, and use of mental health resources among ethnically diverse black women.

Authors:  Bushra Sabri; Richelle Bolyard; Akosoa L McFadgion; Jamila K Stockman; Marguerite B Lucea; Gloria B Callwood; Catherine R Coverston; Jacquelyn C Campbell
Journal:  Soc Work Health Care       Date:  2013

9.  Using Prolonged Exposure and Cognitive Processing Therapy to Treat Veterans with Moral Injury-Based PTSD: Two Case Examples.

Authors:  Philip Held; Brian J Klassen; Michael B Brennan; Alyson K Zalta
Journal:  Cogn Behav Pract       Date:  2017-10-13

10.  Rewarding and unrewarding aspects of deployment to Iraq and its association with psychological health in UK military personnel.

Authors:  Josefin Sundin; Nicola T Fear; Lisa Hull; Norman Jones; Christopher Dandeker; Matthew Hotopf; Simon Wessely; Roberto J Rona
Journal:  Int Arch Occup Environ Health       Date:  2010-01-06       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.